Advertisement
Physicians and health care institutions from around the area donated theirtime to care for the patients, conducting dozens of screenings utilizingSignalife's award-winning Fidelity 100 ECG monitor. The screenings wereconducted free of charge to the patients.
Advertisement
Willie Gault, the Foundation's founder, commented: "During the weekend,doctors reported that they had detected pathology in certain patients that wasnormally difficult or impossible to identify. Also, certain patients remarkedto me that they were previously advised to undergo thousands of dollars ofheart tests by their physicians -- but were given a clean bill of heart healthat the event by the attending physicians. This is why I started theFoundation: To create some certainty in heart health, and to level theplaying field from the perspective of cost and access for all persons. Iwould like to thank all those who donated their time to conduct thesescreenings and evaluations."
About Signalife
Signalife, Inc. is a life sciences company focused on the monitoring,detection and prevention of disease through continuous biomedical signalmonitoring. Signalife uses its patented signal technology to design anddevelop medical devices, therapies and/or technologies that simplify andreduce the costs of cardiovascular disease.
Signalife is publicly traded on the American Stock Exchange under thesymbol SGN. The website for the company is http://www.Signalife.com. ClearData. Trusted Results.
About Athletes for Life Foundation
Athletes for Life Foundation is a District of Columbia Non-ProfitFoundation containing dozens of famous role models and athletes who are tiredof having their friends die at early ages -- or have invasive heart procedures-- when there may be a better way to treat the disease and to save lives. TheFoundation is committed to -- and does in fact -- bring new technologies tohealthcare, it brings life mobiles to communities so that health care comes tothe masses and not visa versa, it provides foundational support for healthcare facilities and hospitals, and "levels the playing field" for alldemographic groups of cultures through competent health care facilities andeducation with the role models and athletes who have made our lives unique indecades of professional sports.
Caution Regarding Forward-Looking Statements
Statements in this release that are not strictly historical are "forward-looking" statements. Forward-looking statements involve known and unknownrisks, which may cause Signalife's actual results in the future to differmaterially from expected results. Factors which could cause or contribute tosuch differences include, but are not limited to, failure to complete thedevelopment and introduction of heart monitoring and other biomedical devicesincorporating Signalife's technology, failure to obtain federal or stateregulatory approvals governing heart monitoring and other biomedical devicesincorporating Signalife's technology, inability to obtain physician, patientor insurance acceptance of for heart monitoring and other biomedicalincorporating Signalife's technology, and the unavailability of financing tocomplete management's plans and objectives, including the development of heartmonitoring and other biomedical incorporating Signalife's technology. Theserisks are qualified in their entirety by cautionary language and risk factorsset forth and to be further described in Signalife's filings with theSecurities and Exchange Commission.
SOURCE Signalife, Inc.
